You are here: Industry Insights > COVID-19

News List

Kamada Signs Supply Agreement with Israeli Health Authorities contractpharma
October 23, 2020
?The Israeli health authorities have signed a supply agreement for the investigational Covid-19 plasma-derived Immunoglobulin (IgG), to be supplied by Kamada Ltd., a biopharmaceutical company which is partnered with Kedrion Biopharma in the development...
Moderna Completes Enrollment in Phase III COVID-19 Vax Study contractpharma
October 23, 2020
?Moderna, Inc. has completed enrollment of 30,000 participants for the Phase 3 COVE study of mRNA-1273, its COVID-19 vaccine candidate, being conducted in collaboration with the National Institutes of Health (NIH) and the Biomedical Advanced Research ...
LaunchWorks CDMO Approved for Viral Transport Media contractpharma
October 23, 2020
?LaunchWorks CDMO has been approved to manufacture and distribute Viral Transport Media, in accordance with Section IV.B of the FDA’s COVID-19 Transport Media Policy.
ABEC Delivers Process Systems to Ology Bio contractpharma
October 23, 2020
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, is delivering process systems to Ology Bioservices Inc. to support their production of critical vaccines and therapeutics for COVID-19.
IAVI, Merck KGaA and Serum Institute partner to develop COVID-19 mAbs expresspharma
October 23, 2020
The partnership aims to ensure access to a class of innovative therapies that have, to date, been out of reach in low- and middle-income countries (LMICs).
Envirotainer Adds 57% more RAP e2 capacity in the US prnasia
October 22, 2020
Envirotainer, the global market leader and by far largest provider of temperature-controlled air freight solutions for pharmaceuticals, announced that they are increasing their RAP e2 network capacity in the US by 57%.
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19 prnewswire
October 22, 2020
Poseida Therapeutics, Inc. and TScan Therapeutics, Inc. announced a research collaboration and license agreement to explore developing TCR-T cell therapies for the treatment of COVID-19.
New Study Finds COVID-19 Substantially Reduced Cancer Screenings, Diagnosis, and Treatments in 2020 prnewswire
October 22, 2020
Breast, colon, prostate, and lung cancers did not stop for COVID-19 in 2020, but screenings and treatments did. Dramatically. The result, say doctors, could be a catastrophe in the making.
Precision Genetics Advances COVID-19 Testing by Adding Saliva Collection Under Existing EUA prnewswire
October 22, 2020
Precision Genetics, a leading healthcare technology company and high capacity molecular testing lab, has added saliva collection to their existing portfolio of validated Covid-19 testing options submitted under Emergency Use Authorization (EUA) by the ...
UK to establish human challenge studies for COVID-19 vaccines europeanpharmaceuticalreview
October 22, 2020
The UK government hopes to expedite the development of a COVID-19 vaccine by investing ￡33.6 million in the first phase of establishing human challenge trials.